H-Tyr-Ala-OH

CAS No. 730-08-5

H-Tyr-Ala-OH( Tyrosylalanine )

Catalog No. M28335 CAS No. 730-08-5

H-Tyr-Ala-OH (Tyrosylalanine) is a L-tyrosine- and L-alanine-containing dipeptide .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 36 In Stock
50MG 52 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    H-Tyr-Ala-OH
  • Note
    Research use only, not for human use.
  • Brief Description
    H-Tyr-Ala-OH (Tyrosylalanine) is a L-tyrosine- and L-alanine-containing dipeptide .
  • Description
    H-Tyr-Ala-OH (Tyrosylalanine) is a L-tyrosine- and L-alanine-containing dipeptide .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tyrosylalanine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    730-08-5
  • Formula Weight
    252.27
  • Molecular Formula
    C12H16N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 125 mg/mL (495.50 mM)
  • SMILES
    C[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ebihara A, Fujimura A. Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet. 1991 Nov;21(5):331-43. Review.
molnova catalog
related products
  • GW6340

    GW6340 is a selective LXR agonist with potential anticancer activity that promotes macrophage reverse cholesterol transport (mRCT) and can be used to study atherosclerosis.

  • Clematichinenoside C

    Clematichinenoside C is a natural product from Clematis chinensis.

  • 3,4-Di-O-caffeoylqui...

    3,4-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV; it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells.